These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 35735408)

  • 1. Postdiction in Visual Awareness in Schizophrenia.
    Kéri S
    Behav Sci (Basel); 2022 Jun; 12(6):. PubMed ID: 35735408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Postdiction in Visual Awareness and Intrinsic Religiosity.
    Kéri S
    Cogn Sci; 2022 Jul; 46(7):e13171. PubMed ID: 35738491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antipsychotic drugs versus cognitive behavioural therapy versus a combination of both in people with psychosis: a randomised controlled pilot and feasibility study.
    Morrison AP; Law H; Carter L; Sellers R; Emsley R; Pyle M; French P; Shiers D; Yung AR; Murphy EK; Holden N; Steele A; Bowe SE; Palmier-Claus J; Brooks V; Byrne R; Davies L; Haddad PM
    Lancet Psychiatry; 2018 May; 5(5):411-423. PubMed ID: 29605187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Raloxifene Plus Antipsychotics Versus Placebo Plus Antipsychotics in Severely Ill Decompensated Postmenopausal Women With Schizophrenia or Schizoaffective Disorder: A Randomized Controlled Trial.
    Weiser M; Levi L; Burshtein S; Hagin M; Matei VP; Podea D; Micluția I; Tiugan A; Păcală B; Grecu IG; Noy A; Zamora D; Davis JM
    J Clin Psychiatry; 2017 Jul; 78(7):e758-e765. PubMed ID: 28541645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive-behavioural therapy for clozapine-resistant schizophrenia: the FOCUS RCT.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe S; French P; Hutton P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TR; Davies L; Shields G; Buck D; Tully S; Kingdon D
    Health Technol Assess; 2019 Feb; 23(7):1-144. PubMed ID: 30806619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: the potential impact of GABA concentration in the visual cortex.
    Kelemen O; Kiss I; Benedek G; Kéri S
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():13-9. PubMed ID: 23954737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mistiming of thought and perception predicts delusionality.
    Bear A; Fortgang RG; Bronstein MV; Cannon TD
    Proc Natl Acad Sci U S A; 2017 Oct; 114(40):10791-10796. PubMed ID: 28923963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of outcome in brief cognitive behavior therapy for schizophrenia.
    Brabban A; Tai S; Turkington D
    Schizophr Bull; 2009 Sep; 35(5):859-64. PubMed ID: 19571248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive behavioural therapy in clozapine-resistant schizophrenia (FOCUS): an assessor-blinded, randomised controlled trial.
    Morrison AP; Pyle M; Gumley A; Schwannauer M; Turkington D; MacLennan G; Norrie J; Hudson J; Bowe SE; French P; Byrne R; Syrett S; Dudley R; McLeod HJ; Griffiths H; Barnes TRE; Davies L; Kingdon D;
    Lancet Psychiatry; 2018 Aug; 5(8):633-643. PubMed ID: 30001930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized controlled trial of olanzapine versus haloperidol in the treatment of primary negative symptoms and neurocognitive deficits in schizophrenia.
    Lindenmayer JP; Khan A; Iskander A; Abad MT; Parker B
    J Clin Psychiatry; 2007 Mar; 68(3):368-79. PubMed ID: 17388705
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses.
    Haddad PM; Correll CU
    Ther Adv Psychopharmacol; 2018 Nov; 8(11):303-318. PubMed ID: 30344997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antipsychotic treatment beyond antipsychotics: metacognitive intervention for schizophrenia patients improves delusional symptoms.
    Moritz S; Veckenstedt R; Randjbar S; Vitzthum F; Woodward TS
    Psychol Med; 2011 Sep; 41(9):1823-32. PubMed ID: 21275083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents.
    Glick ID; Lemmens P; Vester-Blokland E
    Int Clin Psychopharmacol; 2001 Sep; 16(5):265-74. PubMed ID: 11552769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential cognitive performances between schizophrenic responders and non-responders to antipsychotics: correlation with course of the illness, psychopathology, attitude to the treatment and antipsychotics doses.
    de Bartolomeis A; Balletta R; Giordano S; Buonaguro EF; Latte G; Iasevoli F
    Psychiatry Res; 2013 Dec; 210(2):387-95. PubMed ID: 23910239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of adjunctive bitopertin versus placebo in patients with suboptimally controlled symptoms of schizophrenia treated with antipsychotics: results from three phase 3, randomised, double-blind, parallel-group, placebo-controlled, multicentre studies in the SearchLyte clinical trial programme.
    Bugarski-Kirola D; Iwata N; Sameljak S; Reid C; Blaettler T; Millar L; Marques TR; Garibaldi G; Kapur S
    Lancet Psychiatry; 2016 Dec; 3(12):1115-1128. PubMed ID: 27816567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognition, schizophrenia and the effect of antipsychotics].
    Stip E
    Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Study on risk factors of extrapyramidal symptoms induced by antipsychotics and its correlation with symptoms of schizophrenia.
    Weng J; Zhang Y; Li H; Shen Y; Yu W
    Gen Psychiatr; 2019; 32(1):e100026. PubMed ID: 31179423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early predictors of poor treatment response in patients with schizophrenia treated with atypical antipsychotics.
    Chen YL; Chen KP; Chiu CC; Tai MH; Lung FW
    BMC Psychiatry; 2018 Dec; 18(1):376. PubMed ID: 30509308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cognitive-behavioural therapy for patients with schizophrenia: a multicentre randomized controlled trial in Beijing, China.
    Li ZJ; Guo ZH; Wang N; Xu ZY; Qu Y; Wang XQ; Sun J; Yan LQ; Ng RM; Turkington D; Kingdon D
    Psychol Med; 2015 Jul; 45(9):1893-905. PubMed ID: 25532460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.